Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
mirm
/
Mirum Pharmaceuticals Inc
MIRM
Add to Watchlist
105.950
USD
-6.640
-5.90%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
5.50B
Market Cap
Loss
P/E TTM
Mirum Pharmaceuticals Inc
105.950
-6.640
-5.90%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
12.59%
Janus Henderson Investors
9.95%
BlackRock Institutional Trust Company, N.A.
5.13%
Vanguard Capital Management, LLC
3.96%
State Street Investment Management (US)
3.52%
Other
64.85%
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
12.59%
Janus Henderson Investors
9.95%
BlackRock Institutional Trust Company, N.A.
5.13%
Vanguard Capital Management, LLC
3.96%
State Street Investment Management (US)
3.52%
Other
64.85%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
35.04%
Investment Advisor
34.03%
Hedge Fund
16.35%
Private Equity
13.71%
Research Firm
4.01%
Venture Capital
2.55%
Individual Investor
1.37%
Pension Fund
0.65%
Sovereign Wealth Fund
0.43%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
541
68.01M
111.53%
+4.80M
2025Q4
516
59.67M
115.53%
-2.23M
2025Q3
468
57.20M
111.61%
-6.92M
2025Q2
458
58.36M
116.21%
-4.59M
2025Q1
454
57.59M
116.38%
-4.84M
2024Q4
425
56.60M
115.52%
-10.44M
2024Q3
408
56.58M
118.52%
-12.05M
2024Q2
398
57.22M
121.33%
-10.51M
2024Q1
391
57.27M
121.82%
-5.03M
2023Q4
376
54.05M
116.10%
-4.66M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Frazier Life Sciences Management, L.P.
7.68M
12.73%
+884.56K
+13.02%
Jan 23, 2026
Janus Henderson Investors
6.07M
10.05%
+1.07M
+21.36%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
5.19%
+97.33K
+3.21%
Dec 31, 2025
State Street Investment Management (US)
2.14M
3.55%
+797.09K
+59.18%
Dec 31, 2025
Eventide Asset Management, LLC
2.09M
3.47%
-428.98K
-17.01%
Dec 31, 2025
BVF Partners L.P.
1.50M
2.48%
--
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.38M
2.28%
+133.02K
+10.69%
Dec 31, 2025
Novo Holdings A/S
1.26M
2.09%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Virtus LifeSci Biotech Products ETF
2.37%
Invesco Dorsey Wright Healthcare Momentum ETF
1.52%
ALPS Medical Breakthroughs ETF
1.51%
Federated Hermes MDT Small Cap Core ETF
1.14%
First Trust Innovation Leaders ETF
1.03%
Tema Heart & Health ETF
1.02%
First Trust Small Cap Growth AlphaDEX Fund
0.68%
State Street SPDR S&P Biotech ETF
0.58%
First Trust NASDAQ Pharmaceuticals ETF
0.52%
JPMorgan Fundamental Data Science Small Core ETF
0.43%
View more
Virtus LifeSci Biotech Products ETF
Proportion
2.37%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
1.52%
ALPS Medical Breakthroughs ETF
Proportion
1.51%
Federated Hermes MDT Small Cap Core ETF
Proportion
1.14%
First Trust Innovation Leaders ETF
Proportion
1.03%
Tema Heart & Health ETF
Proportion
1.02%
First Trust Small Cap Growth AlphaDEX Fund
Proportion
0.68%
State Street SPDR S&P Biotech ETF
Proportion
0.58%
First Trust NASDAQ Pharmaceuticals ETF
Proportion
0.52%
JPMorgan Fundamental Data Science Small Core ETF
Proportion
0.43%